‘OTC Pharmaceutical Market Set To Grow To Over $130bn By 2018’ Says Visiongain Report

31 July 2018
Pharma

Visiongain has launched a new pharma report Global OTC Pharmaceutical Market Forecast 2018-2028: Forecasts by Product (Cough, Cold and Allergy, Analgesics, Gastrointestinal, Dermatology, Eye Care, Smoking Cessation Aids, Others) and Geography, with Analysis of Leading Companies

The potential of the OTC pharmaceutical market remains significant and it is a growing segment in the largely stagnant overall pharmaceutical market. In the face of looming patent expiry and falling R&D productivity, the consumer healthcare and OTC business offers distinct advantages to pharmaceutical companies looking to create a diverse portfolio of businesses that achieves sustained revenue growth over the next ten years.

The lead analyst of the report commented “The growth of the OTC Pharmaceutical market will be driven by ageing demographics, cost pressures on healthcare providers, liberalisation of regulatory requirements, shifting cultural practices towards self-medication, and the continued switching of drugs from prescription-only to OTC.
Competition from private-label brands, regulatory concerns over OTC switching and the effective marketing of products via the Internet and social media are some of the challenges that OTC manufacturers and brands will need to address in the future.”

Leading companies featured in the report include Bayer AG, GlaxoSmithKline (GSK) Consumer Care, Perrigo Company PLC, Johnson & Johnson, Daiichi Sankyo Co., Ltd, Pfizer Inc., Procter & Gamble, Sanofi S.A, Reckitt Benckiser Group PLC, Cipla, Inc.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongainglobal.com or call her on +44 (0) 207 336 6100

About visiongain
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-to-business reports cusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Pharmaceutical Spray Drying Market Report 2021-2031

The rising prevalence of oncological disorders, lung infections, rising demand for customised drugs coupled with new orphan diseases discoveries, are few of the major reasons responsible for development of pharmaceutical spray drying market.

25 October 2021

Read

Visiongain Publishes Clinical Trial Supplies Market Report 2021-2031

Deviating from protocols raises the danger of missing or delaying data collection from current investigations. This highlights the growing importance of digital medicine, which is being aided by advancements in cloud, mobile, and IoT technology.

11 October 2021

Read

Visiongain Publishes Drug Discovery Informatics Market Report 2021-2031

High performance HPC and supercomputing technology have evolved substantially in China in the last decades, leading to extraordinary accomplishments. HPC-based and combined pharmaceutical chemical and computational biology computational discovery and design has become a significant technique in drug research and development and is sponsored financially by the Chinese government.

07 October 2021

Read

Visiongain Publishes Pharma Wholesale and Distribution Market Report 2021-2031

Many health-care organizations are seeing organic growth at levels that their supply networks were never designed to handle. Others are frantically attempting to integrate diverse technology and procedures as part of a consolidation effort.

06 October 2021

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever